Fig. 4From: Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA)Proportion of patients who achieved SUA level of ≤ 6.0 mg/dL at week 24 (A) and achieving probability according to the SUA levels at baseline (B). Gray zone: 95% confidence interval. SUA: serum uric acidBack to article page